Cargando…
Impact of probiotics on pathogen survival in an innovative human plasma biofilm model (hpBIOM)
BACKGROUND: Despite of medical advances, the number of patients suffering on non-healing chronic wounds is still increasing. This fact is attended by physical and emotional distress and an economic load. The majority of chronic wounds are infected of harmful microbials in a protecting extracellular...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659307/ https://www.ncbi.nlm.nih.gov/pubmed/31345229 http://dx.doi.org/10.1186/s12967-019-1990-4 |
_version_ | 1783439110726221824 |
---|---|
author | Besser, M. Terberger, J. Weber, L. Ghebremedhin, B. Naumova, E. A. Arnold, W. H. Stuermer, E. K. |
author_facet | Besser, M. Terberger, J. Weber, L. Ghebremedhin, B. Naumova, E. A. Arnold, W. H. Stuermer, E. K. |
author_sort | Besser, M. |
collection | PubMed |
description | BACKGROUND: Despite of medical advances, the number of patients suffering on non-healing chronic wounds is still increasing. This fact is attended by physical and emotional distress and an economic load. The majority of chronic wounds are infected of harmful microbials in a protecting extracellular matrix. These biofilms inhibit wound healing. Biofilm-growing bacteria developed unique survival properties, which still challenge the appropriate wound therapy. The present in-vitro biofilm models are not suitable for translational research. By means of a novel in-vivo like human plasma biofilm model (hpBIOM), this study systematically analysed the influence of 3 probiotics on the survival of five clinically relevant pathogenic microorganisms. METHODS: Human plasma was used to produce the innovate biofilm. Pathogenic microorganisms were administered to the plasma. By stimulating the production of a fibrin scaffold, stable coagula-like discs with integrated pathogens were produced. The five clinically relevant pathogens P. aeruginosa, S. aureus, S. epidermidis, E. faecium and C. albicans were challenged to the probiotics L. plantarum, B. lactis and S. cerevisiae. The probiotics were administered on top of the biofilm and the survival was quantified after 4 h and 24 h of incubation. For statistics, two-way ANOVA with post-hoc Tukey’s HSD test was applied. P-value > 0.05 was considered to be significant. RESULTS: SEM micrographs depicted the pathogens on the surface of the fibrin scaffold, arranged in close proximity and produced the glycocalyx. The application of probiotics induced different growth-reducing capacities towards the pathogens. B. lactis and S. cerevisiae showed slight bacteria-reducing properties. The survival of C. albicans was not affected at all. The most antimicrobial activity was detected after the treatment with L. plantarum. CONCLUSIONS: This study successfully reproduced a novel human biofilm model, which provides a human wound milieu and individual immune competence. The success of bacteriotherapy is dependent on the strain combination, the number of probiotics and the activity of the immune cells. The eradicating effect of L. plantarum on P. aeruginosa should be emphasized. |
format | Online Article Text |
id | pubmed-6659307 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66593072019-08-01 Impact of probiotics on pathogen survival in an innovative human plasma biofilm model (hpBIOM) Besser, M. Terberger, J. Weber, L. Ghebremedhin, B. Naumova, E. A. Arnold, W. H. Stuermer, E. K. J Transl Med Research BACKGROUND: Despite of medical advances, the number of patients suffering on non-healing chronic wounds is still increasing. This fact is attended by physical and emotional distress and an economic load. The majority of chronic wounds are infected of harmful microbials in a protecting extracellular matrix. These biofilms inhibit wound healing. Biofilm-growing bacteria developed unique survival properties, which still challenge the appropriate wound therapy. The present in-vitro biofilm models are not suitable for translational research. By means of a novel in-vivo like human plasma biofilm model (hpBIOM), this study systematically analysed the influence of 3 probiotics on the survival of five clinically relevant pathogenic microorganisms. METHODS: Human plasma was used to produce the innovate biofilm. Pathogenic microorganisms were administered to the plasma. By stimulating the production of a fibrin scaffold, stable coagula-like discs with integrated pathogens were produced. The five clinically relevant pathogens P. aeruginosa, S. aureus, S. epidermidis, E. faecium and C. albicans were challenged to the probiotics L. plantarum, B. lactis and S. cerevisiae. The probiotics were administered on top of the biofilm and the survival was quantified after 4 h and 24 h of incubation. For statistics, two-way ANOVA with post-hoc Tukey’s HSD test was applied. P-value > 0.05 was considered to be significant. RESULTS: SEM micrographs depicted the pathogens on the surface of the fibrin scaffold, arranged in close proximity and produced the glycocalyx. The application of probiotics induced different growth-reducing capacities towards the pathogens. B. lactis and S. cerevisiae showed slight bacteria-reducing properties. The survival of C. albicans was not affected at all. The most antimicrobial activity was detected after the treatment with L. plantarum. CONCLUSIONS: This study successfully reproduced a novel human biofilm model, which provides a human wound milieu and individual immune competence. The success of bacteriotherapy is dependent on the strain combination, the number of probiotics and the activity of the immune cells. The eradicating effect of L. plantarum on P. aeruginosa should be emphasized. BioMed Central 2019-07-25 /pmc/articles/PMC6659307/ /pubmed/31345229 http://dx.doi.org/10.1186/s12967-019-1990-4 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Besser, M. Terberger, J. Weber, L. Ghebremedhin, B. Naumova, E. A. Arnold, W. H. Stuermer, E. K. Impact of probiotics on pathogen survival in an innovative human plasma biofilm model (hpBIOM) |
title | Impact of probiotics on pathogen survival in an innovative human plasma biofilm model (hpBIOM) |
title_full | Impact of probiotics on pathogen survival in an innovative human plasma biofilm model (hpBIOM) |
title_fullStr | Impact of probiotics on pathogen survival in an innovative human plasma biofilm model (hpBIOM) |
title_full_unstemmed | Impact of probiotics on pathogen survival in an innovative human plasma biofilm model (hpBIOM) |
title_short | Impact of probiotics on pathogen survival in an innovative human plasma biofilm model (hpBIOM) |
title_sort | impact of probiotics on pathogen survival in an innovative human plasma biofilm model (hpbiom) |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659307/ https://www.ncbi.nlm.nih.gov/pubmed/31345229 http://dx.doi.org/10.1186/s12967-019-1990-4 |
work_keys_str_mv | AT besserm impactofprobioticsonpathogensurvivalinaninnovativehumanplasmabiofilmmodelhpbiom AT terbergerj impactofprobioticsonpathogensurvivalinaninnovativehumanplasmabiofilmmodelhpbiom AT weberl impactofprobioticsonpathogensurvivalinaninnovativehumanplasmabiofilmmodelhpbiom AT ghebremedhinb impactofprobioticsonpathogensurvivalinaninnovativehumanplasmabiofilmmodelhpbiom AT naumovaea impactofprobioticsonpathogensurvivalinaninnovativehumanplasmabiofilmmodelhpbiom AT arnoldwh impactofprobioticsonpathogensurvivalinaninnovativehumanplasmabiofilmmodelhpbiom AT stuermerek impactofprobioticsonpathogensurvivalinaninnovativehumanplasmabiofilmmodelhpbiom |